Yu-Hsi Lin
7PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 17, 2023
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration.Victoria C Yan, Yasaman Barekatain, Yu-Hsi Lin
|Oct 17, 2022
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers.Victoria C Yan, Cong-Dat Pham, Elliot S Ballato
|Sep 27, 2022
A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal Tumors.Wei Zhang, Aurélie Auguste, Xiaoyun Liao
|Nov 24, 2020
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi
|Aug 15, 2018
Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.Yonathan Lissanu Deribe, Yuting Sun, Christopher Terranova
|Jun 13, 2018
An inhibitor of oxidative phosphorylation exploits cancer vulnerability.Jennifer R Molina, Yuting Sun, Marina Protopopova
Pageof 2
Frequent Collaborators
4 joint publications
Florian Muller
4 joint publications
Nikunj Satani
2 joint publications
Steven W Millward
2 joint publications
Yasaman Barekatain
2 joint publications
Cong-Dat Pham
2 joint publications
David Maxwell
2 joint publications
Federica Pisaneschi
2 joint publications
Yuting Sun
2 joint publications
Xiaobo Wang
2 joint publications
Victoria C Yan
